Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yu Liang, Gao Jing-xia, Lei Ma, Li Ni, Ruan Chaolie, Jian Zhou & Liao Guo-yang. (2021) Immunogenicity and safety levels of inactivated quadrivalent influenza vaccine in healthy adults via meta-analysis. Human Vaccines & Immunotherapeutics 17:10, pages 3652-3661.
Read now
Read now
Vu Dinh Thiem, Anne-Laure Chabanon, Marion Fournier, Nathalie Lavis, Nguyen Dang Quang, Vu Hai Ha & Melvin Sanicas. (2021) Safety of a quadrivalent influenza vaccine in Vietnamese healthy subjects aged 6 months and older. Human Vaccines & Immunotherapeutics 17:3, pages 690-693.
Read now
Read now
Yan-Yang Tao, Jing-Xin Li, Yue-Mei Hu, Yuan-Sheng Hu, Gang Zeng & Feng-Cai Zhu. (2021) Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis. Expert Review of Vaccines 20:1, pages 1-11.
Read now
Read now
Ziyan Meng, Jiayou Zhang, Jinrong Shi, Wei Zhao, Xiaoyuan Huang, Li Cheng & Xiaoming Yang. (2020) Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness. Human Vaccines & Immunotherapeutics 16:11, pages 2680-2689.
Read now
Read now
Timo Vesikari, Miia Virta, Seppo Heinonen, Cécile Eymin, Nathalie Lavis, Anne Laure Chabanon & Viviane Gresset-Bourgeois. (2020) Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial. Human Vaccines & Immunotherapeutics 16:3, pages 623-629.
Read now
Read now
Sharad Agarkhedkar, Jugesh Chhatwal, Rajeev Zachariah Kompithra, Sanjay K. Lalwani, Arun Narayan, Vinay Muninarayanaswam, Nithya Gogtay, Kristin Dotter & Viviane Gresset-Bourgeois. (2019) Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India. Human Vaccines & Immunotherapeutics 15:4, pages 973-977.
Read now
Read now
Susanna Esposito. (2018) 100 years since the 1918 influenza pandemic. Human Vaccines & Immunotherapeutics 14:3, pages 504-507.
Read now
Read now
Articles from other publishers (9)
Marilou Kiely, Fazia Tadount, Ernest Lo, Manish Sadarangani, Shu Qin Wei, Ellen Rafferty, Caroline Quach & Shannon E MacDonald. (2023) Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials. Journal of Epidemiology and Community Health 77:12, pages 791-801.
Crossref
Crossref
Kriengkrai Prasert, Prabda Praphasiri, Hatairat Lerdsamran, Sutthichai Nakphook, Darunee Ditsungnoen, Sutthinan Chawalchitiporn, Kanlaya Sornwong, Kittisak Poopipatpol, Ponthip Wirachwong, Piengthong Narakorn, Somchaiya Surichan, Nava Suthepakul, Napawan Thangsupanimitchai, Chakrarat Pittayawonganon, Pilaipan Puthavathana, William W. Davis, Joshua A. Mott, Sonja J. Olsen & Jayanton Patumanond. (2023) Safety and immunogenicity of locally produced trivalent inactivated influenza vaccine (Tri Fluvac) in healthy Thai adults aged 18–64 years in Nakhon Phanom: A Phase III double blinded, three-arm, randomized, controlled trial. Vaccine.
Crossref
Crossref
C. Raina MacIntyre, J. Kevin Yin, Christian Felter, Robert I. Menzies, Edward Thommes, Nathalie Largeron, Aye M. Moa, Mallory Trent, Valentina Costantino, Seulki Choi & Fabián P. Alvarez. (2023) Estimated health and economic impact of using high-dose influenza vaccine on respiratory and circulatory plus respiratory hospitalizations of older adults in Australia. Vaccine: X 15, pages 100365.
Crossref
Crossref
Alice Mannocci, Andrea Pellacchia, Rossella Millevolte, Manuela Chiavarini & Chiara de Waure. (2022) Quadrivalent Vaccines for the Immunization of Adults against Influenza: A Systematic Review of Randomized Controlled Trials. International Journal of Environmental Research and Public Health 19:15, pages 9425.
Crossref
Crossref
Anja Kwetkat, Anne-Sophie Endres, Andreas Leischker & Hans Jürgen Heppner. (2020) Impfen im Alter – Pflicht oder Kür?. DMW - Deutsche Medizinische Wochenschrift 145:16, pages 1133-1137.
Crossref
Crossref
Anja Kwetkat, Hans Jürgen Heppner & Andreas Leischker. (2019) Impfungen bei Senioren: Ein Update. Geriatrie-Report 14:4, pages 34-36.
Crossref
Crossref
Stephanie Pepin, Martin Dupuy, Charissa Fay Corazon Borja-Tabora, May Montellano, Lulu Bravo, Jaime Santos, Jo-Anne de Castro, Doris Maribel Rivera-Medina, Clare Cutland, Miguel Ariza, Javier Diez-Domingo, Celia Diaz Gonzalez, Federico Martinón-Torres, Efimia Papadopoulou-Alataki, Maria Theodoriadou, Marie Pierre Kazek-Duret, Sanjay Gurunathan & Iris De Bruijn. (2019) Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6–35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres. Vaccine 37:13, pages 1876-1884.
Crossref
Crossref
José Antonio López Trigo, Rosa López Mongil, Alberto Mariano Lázaro, Gloria Mato Chaín, Norberto Moreno Villajos & Primitivo Ramos Cordero. (2018) Vacunación frente a la gripe estacional en las personas mayores. Evaluación de la vacuna tetravalente. Informe de posicionamiento. Revista Española de Geriatría y Gerontología 53, pages 185-202.
Crossref
Crossref
Emanuele Montomoli, Alessandro Torelli, Ilaria Manini & Elena Gianchecchi. (2018) Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults. Vaccines 6:1, pages 14.
Crossref
Crossref